Biopharma Trends
Top Picks
-
Key Process Considerations for Therapeutic Oligonucleotides
Learn more about scalable solutions for developing and manufacturing oligonucleotide therapeutics.
-
Novavax Reports on Two Vaccine Efficacy Studies
Novavax’s COVID-19 vaccine is 90.4% effective and maintains efficacy when administered with an influenza vaccine.
More in Biopharma Trends
Knowledge Center
Principles & Methodology Handbooks
Find practical tips and in-depth information about common methodologies used in the lab.
Q&A with Industry Leaders
Top Challenges to Overcome When Developing AAV Processes: Part 1
An interview with Cytiva's Anki Magnusson and Åsa Hagner-McWhirter, PhD